发明名称 Dry eye treatments
摘要 Described herein are methods and pharmaceutical formulations for treating dry eye disease.
申请公布号 US9597284(B2) 申请公布日期 2017.03.21
申请号 US201514887248 申请日期 2015.10.19
申请人 Oyster Point Pharma, Inc. 发明人 Ackermann, Jr. Douglas Michael;Loudin James;Mandell Kenneth J.
分类号 A61K9/00;A61K31/439;A61K31/4439;A61K31/4427;A61K31/4985;A61K45/06;A61K31/4995 主分类号 A61K9/00
代理机构 代理人
主权项 1. A method of treating dry eye, comprising the local administration of a therapeutically effective amount of a nicotinic acetylcholine receptor agonist into the nasal cavity of an individual in need thereof, wherein the agonist selectively binds to the peripheral nicotinic acetylcholine receptor, is administered in a non-systemically bioavailable dose between 5 micrograms and 50 micrograms per dose, and does not cross the blood-brain barrier in a pharmacologically relevant concentration; and wherein the nicotinic acetylcholine receptor agonist is varenicline.
地址 San Francisco CA US